March 03, 2021
1 min read
Outpatient shoulder arthroplasty may be safe for Medicare patients
Medicare patients may be able to safely undergo outpatient shoulder arthroplasty despite a more severe comorbidity burden, according to results presented at the American Shoulder and Elbow Surgeons Specialty Day Meeting.
Using the Duke-Rush Shoulder Consortium database, Grant E. Garrigues, MD, and colleagues reviewed data on Medicare patients with a short hospital stay after shoulder arthroplasty as a proxy for patients who may be appropriate for outpatient shoulder arthroplasty. Researchers reviewed whether Medicare patients were safe to discharge the same day as surgery, which patients were at higher risk for 90-day readmission and which patients were at higher risk of requiring a skilled nursing facility.
Garrigues noted 13 variables predicted the likelihood that patients could have a same-day discharge, including duration of surgery, age, gender and marital status. He added 11 preoperative variables predicted patients at risk for skilled nursing facility admission, as well as 16 preoperative variables that predicted the likelihood that a patient would have a higher readmission rate after same-day discharge.
Grant E. Garrigues
Compared with non-Medicare patients, Garrigues noted Medicare patients who had a short stay after surgery did not have a statistically increased risk of 90-day readmission. However, Medicare patients who had a longer hospital stay trended toward statistical significance for higher readmission rate due to a higher percentage of reverse shoulder arthroplasties performed, according to Garrigues.
“If you look by reverse and anatomic and stratify that, the difference completely goes away,” Garrigues said in his presentation. “So, it is based on ... the higher 90-day readmission rate of the reverse total shoulder arthroplasty and the fact that Medicare patients tend to get that procedure at a higher rate.”
Perspective
Back to Top
Grant E. Garrigues, MD, and colleagues presented a very insightful analysis of more than 5,000 shoulder arthroplasties in an attempt to create a predictive algorithm for postoperative complications and hospital readmissions. This robust database identified several variables that may help the practicing orthopedic surgeon select patients appropriate for same day discharge after shoulder replacement.
Due to many variables, including pressure from payers to deliver value in health care and the on-going COVID-19 pandemic, shoulder surgeons are increasingly transitioning their arthroplasty practices to the outpatient setting. An important consideration is whether the outpatient replacement will be performed in a hospital or ASC. For Medicare patients, CMS has removed total shoulder arthroplasty from the inpatient-only list, which allows same-day discharge from a hospital. However, a reimbursement code has not been assigned as yet for the ASC environment. While this will hopefully follow in the coming months, at the time of this writing, it is important for surgeons to be mindful of medical conditions, payer status and surgical environment when considering outpatient shoulder replacement.
Thomas W. (Quin) Throckmorton, MD, FAAOS
Professor and vice chief of staff
Shoulder and elbow surgery
University of Tennessee-Campbell Clinic
Department of orthopedic surgery
Germantown, Tennessee
Disclosures: Throckmorton reports he is a partner in two surgery centers at the Campbell Clinic that perform outpatient total joint arthroplasty.
Published by:
Sources/DisclosuresCollapse
Source:
Garrigues GE. Outpatient shoulder arthroplasty: Appropriate patient selection. Presented at: American Shoulder and Elbow Surgeons Specialty Day Meeting; Feb. 27, 2021 (virtual meeting).
Disclosures:
Garrigues reports he is a paid consultant for Additive Orthopaedics, DJ Orthopaedics, Mitek and Tornier; is a board or committee member for the American Shoulder and Elbow Surgeons and Arthroscopy Association of North America; receives other financial or material support from Arthrex Inc., DJ Orthopaedics and SouthTech; has stock or stock options in CultivateMD, Genesys, Patient IQ and ROM 3; receives IP royalties from and is a paid presenter or speaker for DJ Orthopaedics and Tornier; and is on the editorial or governing board for the Journal of Shoulder and Elbow Surgery and Techniques in Orthopaedics.